chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, COVID-19, Exposure during pregnancy, Fatigue
Clinical narrative: fever of 101.2 F; Vaccine exposure during pregnancy; and stomach ache; fatigue; headache; itchy arm; tender arm; hot arm; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), VACCINATION SITE WARMTH (hot arm), VACCINATION SITE PRURITUS (itchy arm) and VACCINATION SITE PAIN (tender arm) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot arm), VACCINATION SITE PRURITUS (itchy arm) and VACCINATION SITE PAIN (tender arm). On 17-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 28-Jan-2021, VACCINATION SITE WARMTH (hot arm), VACCINATION SITE PRURITUS (itchy arm) and VACCINATION SITE PAIN (tender arm) had resolved. At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: 101.2 (High) 101.2 F. On 17-Feb-2021, COVID-19: negative (Negative) She tested negative for COVID.         This case was linked to MOD-2021-016110 (Patient Link).
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: fever of 101.2 F; Vaccine exposure during pregnancy; and stomach ache; fatigue; headache; itchy arm; tender arm; hot arm; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), VACCINATION SITE WARMTH (hot arm), VACCINATION SITE PRURITUS (itchy arm) and VACCINATION SITE PAIN (tender arm) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot arm), VACCINATION SITE PRURITUS (itchy arm) and VACCINATION SITE PAIN (tender arm). On 17-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 28-Jan-2021, VACCINATION SITE WARMTH (hot arm), VACCINATION SITE PRURITUS (itchy arm) and VACCINATION SITE PAIN (tender arm) had resolved. At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: 101.2 (High) 101.2 F. On 17-Feb-2021, COVID-19: negative (Negative) She tested negative for COVID.         This case was linked to MOD-2021-016110 (Patient Link).
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Neck pain, Pain in extremity
Clinical narrative: Progressive and gradual pain at the neck; Sore arm; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 20-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Progressive and gradual pain at the neck), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032120A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced NECK PAIN (Progressive and gradual pain at the neck), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache). At the time of the report, NECK PAIN (Progressive and gradual pain at the neck), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) outcome was unknown.            This case was linked to MOD-2021-091001, MOD-2021-091001 (Patient Link).   Reporter did not allow further contact
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus
Clinical narrative: Redness at the injection site; Hardness at the injection site; Itchiness at the injection site; A spontaneous report was received from a 94  year old , female patient , who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced redness at the injection site/vaccination site erythema , hardness at the injection site/ vaccination site induration and itchiness at the injection site/vaccination site pruritis.  The patient's medical history was not provided. Concomitant product use was not provided.  On an unknown date, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273(Batch number : unknown) via unknown route for prophylaxis of COVID-19 infection. On 19 Feb 2021, prior to the onset of events, the patient received their second of two planned doses of mRNA-1273 (Batch number : unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 19 Feb 2021, after receiving mRNA-1273, the patient experienced redness , hardness and itching at the injection site. The reporter wants to know what to do regarding her symptoms. Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.  The outcome of the events, redness, hardness and itching at the injection site were not considered to be resolved at the time of report.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pruritus, Vaccination site urticaria
Clinical narrative: Single hive on bettly/Hive an inch below injection site/Hive on face above eyebrow; Intense itching above injection site; Splotchy rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (Single hive on bettly/Hive an inch below injection site/Hive on face above eyebrow), VACCINATION SITE PRURITUS (Intense itching above injection site) and RASH (Splotchy rash) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012m20a) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (Single hive on bettly/Hive an inch below injection site/Hive on face above eyebrow), VACCINATION SITE PRURITUS (Intense itching above injection site) and RASH (Splotchy rash). At the time of the report, VACCINATION SITE URTICARIA (Single hive on bettly/Hive an inch below injection site/Hive on face above eyebrow), VACCINATION SITE PRURITUS (Intense itching above injection site) and RASH (Splotchy rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-090160 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dizziness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (extremely dizzy similar or worse than Vertigo, dizziness is worsening by the hour) and CONDITION AGGRAVATED (Extremely dizzy) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for an unknown indication. Concurrent medical conditions included Diabetes. On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced DIZZINESS (extremely dizzy similar or worse than Vertigo, dizziness is worsening by the hour) and CONDITION AGGRAVATED (Extremely dizzy). On 22-Feb-2021, DIZZINESS (extremely dizzy similar or worse than Vertigo, dizziness is worsening by the hour) and CONDITION AGGRAVATED (Extremely dizzy) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications was reported. No treatment details was specified. Reporter did not allow further contact. Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow up received on 26 Apr 2021 included: reporter contact details, updated the outcome of the event (dizziness) and patient's medical history.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: the arm of the shot has been very achy; mild headache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE PAIN (the arm of the shot has been very achy) and HEADACHE (mild headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (the arm of the shot has been very achy) and HEADACHE (mild headache). At the time of the report, VACCINATION SITE PAIN (the arm of the shot has been very achy) and HEADACHE (mild headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Gait disturbance, Neck pain, Pain in extremity
Clinical narrative: right ankle joint so much in pain; couldn't walk for 24 hours; elbow pain; neck pain on the left side; wrist pain; severe pain in his left shoulder; fingers pain; pain left cervical; severe pain in his left arm; weakness left cervica; This spontaneous case was reported by a nurse and describes the occurrence of ARTHRALGIA (right ankle joint so much in pain), GAIT DISTURBANCE (couldn't walk for 24 hours), ARTHRALGIA (elbow pain), NECK PAIN (neck pain on the left side) and ARTHRALGIA (wrist pain) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, the patient experienced ARTHRALGIA (right ankle joint so much in pain), GAIT DISTURBANCE (couldn't walk for 24 hours), ARTHRALGIA (elbow pain), NECK PAIN (neck pain on the left side), ARTHRALGIA (wrist pain), ARTHRALGIA (severe pain in his left shoulder), PAIN IN EXTREMITY (fingers pain), NECK PAIN (pain left cervical), PAIN IN EXTREMITY (severe pain in his left arm) and ASTHENIA (weakness left cervica). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (right ankle joint so much in pain), GAIT DISTURBANCE (couldn't walk for 24 hours), ARTHRALGIA (elbow pain), NECK PAIN (neck pain on the left side), ARTHRALGIA (wrist pain), ARTHRALGIA (severe pain in his left shoulder), PAIN IN EXTREMITY (fingers pain), NECK PAIN (pain left cervical), PAIN IN EXTREMITY (severe pain in his left arm) and ASTHENIA (weakness left cervica) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information was not provided
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over) and PRURITUS (his entire body was itching) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not reported.). Concurrent medical conditions included Cholesterol and Heart disease, unspecified. Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced PRURITUS (Itching all over). On 17-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRURITUS (his entire body was itching). At the time of the report, PRURITUS (Itching all over) outcome was unknown and PRURITUS (his entire body was itching) had not resolved.            Treatment information included Lotion,Rubbing alcohol. Concomitant med also include: Blood thinners and heart medicine   This case was linked to MOD-2021-018398 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: NNI
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Fatigue, Headache, Injection site pain
Clinical narrative: Anxiety; Headache; Soreness at  injection site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety), HEADACHE (Headache), INJECTION SITE PAIN (Soreness at  injection site) and FATIGUE (Fatigue) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2021, the patient experienced HEADACHE (Headache), INJECTION SITE PAIN (Soreness at  injection site) and FATIGUE (Fatigue). On 19-Feb-2021, the patient experienced ANXIETY (Anxiety). At the time of the report, ANXIETY (Anxiety) outcome was unknown and HEADACHE (Headache), INJECTION SITE PAIN (Soreness at  injection site) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not reported  Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 19-Feb-2021: No specific follow-up information recorded.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Contusion, Dizziness, Feeling abnormal, Headache
Clinical narrative: Stinging sensation; Slight headache; Arm started hurting; Hands were tingling; Felt numb; Rapid heartbeat/ heart was racing; Chills on and off; Dizziness; Foggy feeling in brain; Vaccination site erythema; Bruised; Hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling) and HYPOAESTHESIA (Felt numb) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (Shrimp).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling), HYPOAESTHESIA (Felt numb), HEART RATE INCREASED (Rapid heartbeat/ heart was racing), CHILLS (Chills on and off), DIZZINESS (Dizziness), FEELING ABNORMAL (Foggy feeling in brain), VACCINATION SITE ERYTHEMA (Vaccination site erythema), CONTUSION (Bruised) and VACCINATION SITE WARMTH (Hot to the touch). At the time of the report, PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling), HYPOAESTHESIA (Felt numb), HEART RATE INCREASED (Rapid heartbeat/ heart was racing), CHILLS (Chills on and off), DIZZINESS (Dizziness), FEELING ABNORMAL (Foggy feeling in brain), VACCINATION SITE ERYTHEMA (Vaccination site erythema), CONTUSION (Bruised) and VACCINATION SITE WARMTH (Hot to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not reported  Treatment information was not provided
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Hypoaesthesia, Pain, Pain in extremity, Paraesthesia
Clinical narrative: Stinging sensation; Slight headache; Arm started hurting; Hands were tingling; Felt numb; Rapid heartbeat/ heart was racing; Chills on and off; Dizziness; Foggy feeling in brain; Vaccination site erythema; Bruised; Hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling) and HYPOAESTHESIA (Felt numb) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (Shrimp).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling), HYPOAESTHESIA (Felt numb), HEART RATE INCREASED (Rapid heartbeat/ heart was racing), CHILLS (Chills on and off), DIZZINESS (Dizziness), FEELING ABNORMAL (Foggy feeling in brain), VACCINATION SITE ERYTHEMA (Vaccination site erythema), CONTUSION (Bruised) and VACCINATION SITE WARMTH (Hot to the touch). At the time of the report, PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling), HYPOAESTHESIA (Felt numb), HEART RATE INCREASED (Rapid heartbeat/ heart was racing), CHILLS (Chills on and off), DIZZINESS (Dizziness), FEELING ABNORMAL (Foggy feeling in brain), VACCINATION SITE ERYTHEMA (Vaccination site erythema), CONTUSION (Bruised) and VACCINATION SITE WARMTH (Hot to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not reported  Treatment information was not provided
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Stinging sensation; Slight headache; Arm started hurting; Hands were tingling; Felt numb; Rapid heartbeat/ heart was racing; Chills on and off; Dizziness; Foggy feeling in brain; Vaccination site erythema; Bruised; Hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling) and HYPOAESTHESIA (Felt numb) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (Shrimp).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling), HYPOAESTHESIA (Felt numb), HEART RATE INCREASED (Rapid heartbeat/ heart was racing), CHILLS (Chills on and off), DIZZINESS (Dizziness), FEELING ABNORMAL (Foggy feeling in brain), VACCINATION SITE ERYTHEMA (Vaccination site erythema), CONTUSION (Bruised) and VACCINATION SITE WARMTH (Hot to the touch). At the time of the report, PAIN (Stinging sensation), HEADACHE (Slight headache), PAIN IN EXTREMITY (Arm started hurting), PARAESTHESIA (Hands were tingling), HYPOAESTHESIA (Felt numb), HEART RATE INCREASED (Rapid heartbeat/ heart was racing), CHILLS (Chills on and off), DIZZINESS (Dizziness), FEELING ABNORMAL (Foggy feeling in brain), VACCINATION SITE ERYTHEMA (Vaccination site erythema), CONTUSION (Bruised) and VACCINATION SITE WARMTH (Hot to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not reported  Treatment information was not provided
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Fatigue, Headache, Malaise
Clinical narrative: feels sick all day; feels like she has a bug; cough; no strength; sore around injection site; headache; very tired; nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feels sick all day), MALAISE (feels like she has a bug), COUGH (cough), ASTHENIA (no strength) and VACCINATION SITE PAIN (sore around injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concurrent medical conditions included Diabetes mellitus and Hypertension. Concomitant products included Insulin fast acting for Diabetes mellitus, SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced MALAISE (feels sick all day), MALAISE (feels like she has a bug), COUGH (cough), ASTHENIA (no strength), VACCINATION SITE PAIN (sore around injection site), HEADACHE (headache), FATIGUE (very tired) and NAUSEA (nausea). At the time of the report, MALAISE (feels sick all day), MALAISE (feels like she has a bug), COUGH (cough), ASTHENIA (no strength), VACCINATION SITE PAIN (sore around injection site), HEADACHE (headache), FATIGUE (very tired) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment include cough drops.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: The follow-up was received on 26-APR-2021 and include NNI
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site pain
Clinical narrative: feels sick all day; feels like she has a bug; cough; no strength; sore around injection site; headache; very tired; nausea; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feels sick all day), MALAISE (feels like she has a bug), COUGH (cough), ASTHENIA (no strength) and VACCINATION SITE PAIN (sore around injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.  Concurrent medical conditions included Diabetes mellitus and Hypertension. Concomitant products included Insulin fast acting for Diabetes mellitus, SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced MALAISE (feels sick all day), MALAISE (feels like she has a bug), COUGH (cough), ASTHENIA (no strength), VACCINATION SITE PAIN (sore around injection site), HEADACHE (headache), FATIGUE (very tired) and NAUSEA (nausea). At the time of the report, MALAISE (feels sick all day), MALAISE (feels like she has a bug), COUGH (cough), ASTHENIA (no strength), VACCINATION SITE PAIN (sore around injection site), HEADACHE (headache), FATIGUE (very tired) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment include cough drops.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: The follow-up was received on 26-APR-2021 and include NNI
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site discolouration, Injection site induration, Injection site pain, Injection site scab, Injection site swelling
Clinical narrative: injection site swelling; injection site knot; injection site tenderness; injection site black; injection site has a scab; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (injection site swelling), INJECTION SITE INDURATION (injection site knot), INJECTION SITE PAIN (injection site tenderness), INJECTION SITE DISCOLOURATION (injection site black) and INJECTION SITE SCAB (injection site has a scab) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical information provided).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING (injection site swelling), INJECTION SITE INDURATION (injection site knot), INJECTION SITE PAIN (injection site tenderness), INJECTION SITE DISCOLOURATION (injection site black) and INJECTION SITE SCAB (injection site has a scab). At the time of the report, INJECTION SITE SWELLING (injection site swelling), INJECTION SITE INDURATION (injection site knot), INJECTION SITE PAIN (injection site tenderness), INJECTION SITE DISCOLOURATION (injection site black) and INJECTION SITE SCAB (injection site has a scab) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication nor treatment provided
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Mammogram, Nipple pain
Clinical narrative: pain in the nipple; breast pain was in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of NIPPLE PAIN (pain in the nipple) and BREAST PAIN (breast pain was in the left arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced NIPPLE PAIN (pain in the nipple) and BREAST PAIN (breast pain was in the left arm). At the time of the report, NIPPLE PAIN (pain in the nipple) and BREAST PAIN (breast pain was in the left arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Mammogram: benign benign.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was expected to receive second dose of vaccine on 04-Feb-2021 but she did not decide which arm to get second dose.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Myalgia, Pain
Clinical narrative: Pain; Sweat; Fever; Chills; Body aches; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), HYPERHIDROSIS (Sweat), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (Pain), HYPERHIDROSIS (Sweat), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) for Myalgia, Chills, Fever, Pain, Sweaty and Tiredness, at an unspecified dose and frequency. At the time of the report, PAIN (Pain), HYPERHIDROSIS (Sweat), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Pain; Sweat; Fever; Chills; Body aches; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), HYPERHIDROSIS (Sweat), PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Body aches) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (Pain), HYPERHIDROSIS (Sweat), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) for Myalgia, Chills, Fever, Pain, Sweaty and Tiredness, at an unspecified dose and frequency. At the time of the report, PAIN (Pain), HYPERHIDROSIS (Sweat), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Body aches) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Laziness
Clinical narrative: lazy; severe headache; feel tired; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Induration, Pain in extremity, Pruritus, Vaccination site erythema
Clinical narrative: injection site is severely itchy; injection site is bright red; right arm was red; right arm was hard; right arm was itchy; right arm was painful; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (right arm was red), INDURATION (right arm was hard), PRURITUS (right arm was itchy), PAIN IN EXTREMITY (right arm was painful) and VACCINATION SITE PRURITUS (injection site is severely itchy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced ERYTHEMA (right arm was red), INDURATION (right arm was hard), PRURITUS (right arm was itchy) and PAIN IN EXTREMITY (right arm was painful). On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (injection site is severely itchy) and VACCINATION SITE ERYTHEMA (injection site is bright red). On 02-Feb-2021, ERYTHEMA (right arm was red), INDURATION (right arm was hard), PRURITUS (right arm was itchy) and PAIN IN EXTREMITY (right arm was painful) had resolved. At the time of the report, VACCINATION SITE PRURITUS (injection site is severely itchy) and VACCINATION SITE ERYTHEMA (injection site is bright red) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2021: No new information was reported
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: injection site is severely itchy; injection site is bright red; right arm was red; right arm was hard; right arm was itchy; right arm was painful; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (right arm was red), INDURATION (right arm was hard), PRURITUS (right arm was itchy), PAIN IN EXTREMITY (right arm was painful) and VACCINATION SITE PRURITUS (injection site is severely itchy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced ERYTHEMA (right arm was red), INDURATION (right arm was hard), PRURITUS (right arm was itchy) and PAIN IN EXTREMITY (right arm was painful). On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (injection site is severely itchy) and VACCINATION SITE ERYTHEMA (injection site is bright red). On 02-Feb-2021, ERYTHEMA (right arm was red), INDURATION (right arm was hard), PRURITUS (right arm was itchy) and PAIN IN EXTREMITY (right arm was painful) had resolved. At the time of the report, VACCINATION SITE PRURITUS (injection site is severely itchy) and VACCINATION SITE ERYTHEMA (injection site is bright red) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2021: No new information was reported
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Red; seems to grow; Tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Tender), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE SWELLING (seems to grow) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     The patient's past medical history included Pneumonia.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (Tender). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE SWELLING (seems to grow). At the time of the report, VACCINATION SITE PAIN (Tender), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE SWELLING (seems to grow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information provided. No treatment information provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Itchy (at injection site); red at injection site; Sore (at injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy (at injection site)), VACCINATION SITE ERYTHEMA (red at injection site) and VACCINATION SITE PAIN (Sore (at injection site)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchy (at injection site)), VACCINATION SITE ERYTHEMA (red at injection site) and VACCINATION SITE PAIN (Sore (at injection site)). At the time of the report, VACCINATION SITE PRURITUS (Itchy (at injection site)), VACCINATION SITE ERYTHEMA (red at injection site) and VACCINATION SITE PAIN (Sore (at injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chest discomfort, Chest pain, Cough, Erythema
Clinical narrative: Coughing a lot; Runny nose; Rising blood pressure occurred after getting the vaccine; Headaches; Nausea; Can not walk because of fast heart beating.; Pains at arm and chest; Pains at arm and chest; Redness; Aweight on the chest; Can not walk because of fast heart beating; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Pains at arm and chest), CHEST PAIN (Pains at arm and chest), ERYTHEMA (Redness), CHEST DISCOMFORT (Aweight on the chest) and PALPITATIONS (Can not walk because of fast heart beating) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Contrast media allergy (A nurse thinks that patient is allergic to dye contrast).    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pains at arm and chest), CHEST PAIN (Pains at arm and chest), ERYTHEMA (Redness), CHEST DISCOMFORT (Aweight on the chest), PALPITATIONS (Can not walk because of fast heart beating), GAIT DISTURBANCE (Can not walk because of fast heart beating.) and NAUSEA (Nausea). On an unknown date, the patient experienced COUGH (Coughing a lot), RHINORRHOEA (Runny nose), HYPERTENSION (Rising blood pressure occurred after getting the vaccine) and HEADACHE (Headaches). At the time of the report, PAIN IN EXTREMITY (Pains at arm and chest), CHEST PAIN (Pains at arm and chest), ERYTHEMA (Redness), CHEST DISCOMFORT (Aweight on the chest), PALPITATIONS (Can not walk because of fast heart beating), COUGH (Coughing a lot), RHINORRHOEA (Runny nose), HYPERTENSION (Rising blood pressure occurred after getting the vaccine), GAIT DISTURBANCE (Can not walk because of fast heart beating.), HEADACHE (Headaches) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Blood pressure measurement: 180/110 (High) 180/110 mmHg.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient after some minutes of receiving the vaccine began to experience a rise in the blood pressure. The blood pressure value noted was 180/110 mm Hg. The patient also experienced nausea, pains at chest, arm, and redness for 12 times went to emergency room. The patient felt like they had a weight on the chest and was not able to walk because of fast heart beating. The patient also reports of having headaches, and was coughing a lot, including runny nose.   The patient was treated with blood pressure medication because of the rising blood pressure occurred post receiving the vaccine.   Reportedly, a nurse thinks that the patient was allergic to dye contrast.  No Concomitant product use was reported.
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Headache, Hypertension, Nausea, Pain in extremity
Clinical narrative: Coughing a lot; Runny nose; Rising blood pressure occurred after getting the vaccine; Headaches; Nausea; Can not walk because of fast heart beating.; Pains at arm and chest; Pains at arm and chest; Redness; Aweight on the chest; Can not walk because of fast heart beating; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Pains at arm and chest), CHEST PAIN (Pains at arm and chest), ERYTHEMA (Redness), CHEST DISCOMFORT (Aweight on the chest) and PALPITATIONS (Can not walk because of fast heart beating) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Contrast media allergy (A nurse thinks that patient is allergic to dye contrast).    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pains at arm and chest), CHEST PAIN (Pains at arm and chest), ERYTHEMA (Redness), CHEST DISCOMFORT (Aweight on the chest), PALPITATIONS (Can not walk because of fast heart beating), GAIT DISTURBANCE (Can not walk because of fast heart beating.) and NAUSEA (Nausea). On an unknown date, the patient experienced COUGH (Coughing a lot), RHINORRHOEA (Runny nose), HYPERTENSION (Rising blood pressure occurred after getting the vaccine) and HEADACHE (Headaches). At the time of the report, PAIN IN EXTREMITY (Pains at arm and chest), CHEST PAIN (Pains at arm and chest), ERYTHEMA (Redness), CHEST DISCOMFORT (Aweight on the chest), PALPITATIONS (Can not walk because of fast heart beating), COUGH (Coughing a lot), RHINORRHOEA (Runny nose), HYPERTENSION (Rising blood pressure occurred after getting the vaccine), GAIT DISTURBANCE (Can not walk because of fast heart beating.), HEADACHE (Headaches) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Blood pressure measurement: 180/110 (High) 180/110 mmHg.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient after some minutes of receiving the vaccine began to experience a rise in the blood pressure. The blood pressure value noted was 180/110 mm Hg. The patient also experienced nausea, pains at chest, arm, and redness for 12 times went to emergency room. The patient felt like they had a weight on the chest and was not able to walk because of fast heart beating. The patient also reports of having headaches, and was coughing a lot, including runny nose.   The patient was treated with blood pressure medication because of the rising blood pressure occurred post receiving the vaccine.   Reportedly, a nurse thinks that the patient was allergic to dye contrast.  No Concomitant product use was reported.
Sex: M
Vaccine: COVID19
Symptoms: Palpitations, Rhinorrhoea
Clinical narrative: Coughing a lot; Runny nose; Rising blood pressure occurred after getting the vaccine; Headaches; Nausea; Can not walk because of fast heart beating.; Pains at arm and chest; Pains at arm and chest; Redness; Aweight on the chest; Can not walk because of fast heart beating; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Pains at arm and chest), CHEST PAIN (Pains at arm and chest), ERYTHEMA (Redness), CHEST DISCOMFORT (Aweight on the chest) and PALPITATIONS (Can not walk because of fast heart beating) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Contrast media allergy (A nurse thinks that patient is allergic to dye contrast).    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pains at arm and chest), CHEST PAIN (Pains at arm and chest), ERYTHEMA (Redness), CHEST DISCOMFORT (Aweight on the chest), PALPITATIONS (Can not walk because of fast heart beating), GAIT DISTURBANCE (Can not walk because of fast heart beating.) and NAUSEA (Nausea). On an unknown date, the patient experienced COUGH (Coughing a lot), RHINORRHOEA (Runny nose), HYPERTENSION (Rising blood pressure occurred after getting the vaccine) and HEADACHE (Headaches). At the time of the report, PAIN IN EXTREMITY (Pains at arm and chest), CHEST PAIN (Pains at arm and chest), ERYTHEMA (Redness), CHEST DISCOMFORT (Aweight on the chest), PALPITATIONS (Can not walk because of fast heart beating), COUGH (Coughing a lot), RHINORRHOEA (Runny nose), HYPERTENSION (Rising blood pressure occurred after getting the vaccine), GAIT DISTURBANCE (Can not walk because of fast heart beating.), HEADACHE (Headaches) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Blood pressure measurement: 180/110 (High) 180/110 mmHg.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient after some minutes of receiving the vaccine began to experience a rise in the blood pressure. The blood pressure value noted was 180/110 mm Hg. The patient also experienced nausea, pains at chest, arm, and redness for 12 times went to emergency room. The patient felt like they had a weight on the chest and was not able to walk because of fast heart beating. The patient also reports of having headaches, and was coughing a lot, including runny nose.   The patient was treated with blood pressure medication because of the rising blood pressure occurred post receiving the vaccine.   Reportedly, a nurse thinks that the patient was allergic to dye contrast.  No Concomitant product use was reported.